This inventor holds 2 USPTO granted patents. Top assignee: Institute of Animal Sciences of Caas. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations in Veterinary Medicine: The Contributions of Qianqian Feng
Introduction
Qianqian Feng is a notable inventor based in Beijing, China. He has made significant contributions to the field of veterinary medicine, particularly in the development of nanobodies for the diagnosis and treatment of canine parvovirus (CPV). With a total of 2 patents, his work is paving the way for advancements in immunology and veterinary biological products.
Latest Patents
Qianqian Feng's latest patents include the development of two specific nanobodies targeting canine parvovirus. The first patent, titled "Canine parvovirus (CPV) nanobody CPV-VHH-H1 and use thereof," describes a heavy-chain variable region sequence of the nanobody CPV-VHH-H1. This nanobody has been shown to specifically bind to CPV, providing a foundation for clinical applications in veterinary medicine. The second patent, "Canine parvovirus nanobody CPV-VHH-E3 and application thereof," also focuses on a nanobody that can be utilized for the diagnosis and treatment of CPV. Both patents utilize phage display technology to construct a nanobody immune library, demonstrating the potential for these innovations in veterinary biological products.
Career Highlights
Qianqian Feng is affiliated with the Institute of Animal Sciences of the Chinese Academy of Agricultural Sciences. His work at this prestigious institution has allowed him to focus on the intersection of immunology and veterinary science, leading to groundbreaking advancements in the treatment of viral infections in animals.
Collaborations
Qianqian Feng collaborates with esteemed colleagues such as Hongfei Zhu and Weifeng Yuan. Their combined expertise enhances the research and development efforts in the field of veterinary medicine.
Conclusion
Qianqian Feng's innovative work in developing nanobodies for canine parvovirus represents a significant advancement in veterinary medicine. His contributions are expected to have a lasting impact on the field, improving clinical outcomes for affected animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile